Biohaven Ltd.: Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New ...
Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression ...
Reuters22 小时
Global Market Headlines | Breaking Stock Market News | Reuters
A street sign for Wall Street is seen outside the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S. December 28, 2016. REUTERS/Andrew Kelly/File Photo Wall Street's main indexes ...